50% OFF SITEWIDE · Orders before 4PM PST ship same day
50% OFF SITEWIDEOrders before 4PM PST ship same day

Endocrine Signaling Research Peptides

99%+ purity, HPLC verified · ISO 17025 third-party labs · Same-day shipping before 4PM PT · Free shipping over $200

The Pristine Sale50% off sitewideOrders before 4PM PST ship same day

GHRH analogs and ghrelin receptor agonists used to study somatotropic axis signaling and pulsatility in preclinical research, including Sermorelin, Tesamorelin, CJC-1295, Ipamorelin and GHRP-6. U.S. manufactured, third-party tested to ≥99% purity, COA included. For laboratory research use only. Not for human or veterinary use.

What this collection covers

The somatotropic axis is the signaling chain from the hypothalamus to the pituitary to the liver that governs growth hormone and IGF-1. It is one of the best-mapped endocrine systems and a standard model for studying pulsatile hormone release, receptor desensitization and feedback. The peptides in this collection are the tools used to probe it, in pituitary cell cultures, perifusion systems and rodent models.

They fall into two mechanistic classes. GHRH analogs (Sermorelin, Tesamorelin, CJC-1295) act at the GHRH receptor on pituitary somatotrophs and differ mainly in how long they persist. Ghrelin receptor agonists (Ipamorelin, GHRP-6) act at a separate receptor, GHS-R1a, and are studied both for their pituitary effects and for the receptor's roles elsewhere. IGF-1 LR3, the downstream effector in a form engineered for cell culture, completes the axis. Our overview GHRH Analogs vs Ghrelin Receptor Agonists explains the two pathways in detail.

Compounds in this collection

  • Sermorelin — the 29-residue active fragment of GHRH, the reference GHRH analog.
  • Tesamorelin — a stabilized GHRH analog with a modified N-terminus that resists enzymatic cleavage.
  • CJC-1295 — a GHRH analog with four amino-acid substitutions; see with and without DAC.
  • Ipamorelin — a selective pentapeptide ghrelin receptor agonist.
  • GHRP-6 — the first-generation hexapeptide ghrelin receptor agonist.
  • CJC-1295 + Ipamorelin and Tesamorelin + Ipamorelin — one GHRH analog plus one ghrelin agonist in a single vial, for dual-receptor study designs.
  • IGF-1 LR3 — a 83-residue IGF-1 analog with reduced binding-protein affinity, the standard form for cell culture.

Frequently asked questions

What is the difference between a GHRH analog and a ghrelin receptor agonist?

They bind different receptors on the same pituitary cell. GHRH analogs act at the GHRH receptor through a cAMP pathway; ghrelin receptor agonists act at GHS-R1a through a calcium pathway. In pituitary cultures the two together produce a larger response than either alone, which is the rationale for the blended vials.

Why does CJC-1295 come with and without DAC?

DAC (Drug Affinity Complex) is a lysine-linked group that lets the peptide bind serum albumin and persist for days instead of minutes. The version in our catalog and blends is the no-DAC form, which gives a short, defined signal that is easier to interpret in pulsatility experiments.

Why is IGF-1 LR3 in this collection?

IGF-1 is the hormone produced downstream of growth hormone, so it belongs to the same axis. The LR3 form has an N-terminal extension and an arginine substitution that stop it being sequestered by binding proteins in culture medium, which is why it replaced native IGF-1 as the cell-culture standard.

For laboratory and research use only. Not for human or veterinary use, consumption, or therapeutic application.